ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2463
0,01%
Bitcoin
67.726,90
0,36%
Brent Oil
81,295
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Europa
  5. EU
  6. Biosenic (BIOS)

  7. Biosenic (BIOS) Notícias

BIOS

Biosenic (BIOS)

Biosenic
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:EU:BIOS
DataHoraFonteTítuloCódigoCompanhia
31/05/202402:00GlobeNewswire Inc.BioSenic S.A. : Information on the total number of voting rights and sharesEU:BIOSBiosenic
31/05/202402:00GlobeNewswire Inc.BioSenic S.A. : Information relative au nombre total de droits de vote et d’actionsEU:BIOSBiosenic
27/05/202412:00GlobeNewswire Inc.BioSenic S.A. : Positive vote of the majority of creditors in favor of the global restructuring plan of BioSenic covering the years 2024-2032, at the Enterprise Court of NivellesEU:BIOSBiosenic
27/05/202412:00GlobeNewswire Inc.BioSenic S.A. : Vote positif de la majorité des créanciers en faveur du plan global de restructuration de BioSenic couvrant les années 2024-2032, au Tribunal d'Entreprise de NivellesEU:BIOSBiosenic
24/05/202412:00GlobeNewswire Inc.BioSenic provides First Quarter 2024 Business UpdateEU:BIOSBiosenic
24/05/202412:00GlobeNewswire Inc.BioSenic fait le point sur ses activités du premier trimestre 2024EU:BIOSBiosenic
30/04/202402:00GlobeNewswire Inc.BioSenic S.A. : Information on the total number of voting rights and sharesEU:BIOSBiosenic
26/04/202412:30GlobeNewswire Inc.BioSenic publie sur son site web le plan de restructuration soumis au tribunal des entreprises de Nivelles  EU:BIOSBiosenic
26/04/202412:30GlobeNewswire Inc.BioSenic publishes on its website the restructuring plan submitted to the Enterprise Court of NivellesEU:BIOSBiosenic
24/04/202402:00GlobeNewswire Inc.BioSenic reporte son assemblée générale annuelle des actionnaires et fournit des chiffres financiers temporaires non-audités pour 2023EU:BIOSBiosenic
24/04/202402:00GlobeNewswire Inc.BioSenic postpones its annual general meeting of the shareholders and provides temporary non-audited financial figures for 2023EU:BIOSBiosenic
18/04/202402:00GlobeNewswire Inc.BioSenic S.A. : Notifications de transparence reçues de la part de François RiegerEU:BIOSBiosenic
18/04/202402:00GlobeNewswire Inc.BioSenic S.A. : Transparency notifications received from François RiegerEU:BIOSBiosenic
12/04/202407:00GlobeNewswire Inc.BioSenic provides further information on its restructuring planEU:BIOSBiosenic
12/04/202407:00GlobeNewswire Inc.BioSenic fournit des informations complémentaires sur son plan de restructurationEU:BIOSBiosenic
11/04/202409:00GlobeNewswire Inc.BioSenic and its restructuring practitioner (Me Yves Brulard) submit a global restructuring plan covering the years 2024-2030 to the Enterprise Court of NivellesEU:BIOSBiosenic
11/04/202409:00GlobeNewswire Inc.BioSenic et son praticien de la restructuration (Me Yves Brulard) soumettent un plan de restructuration global engageant les années 2024-2030 au Tribunal de l’entreprise de NivellesEU:BIOSBiosenic
29/03/202403:00GlobeNewswire Inc.BioSenic S.A. : Information relative au nombre total de droits de vote et d’actions  EU:BIOSBiosenic
20/03/202403:00GlobeNewswire Inc.BioSenic présente des données précliniques concluantes sur son médicament ATO pour le contrôle des principaux symptômes au Congrès mondial 2024 sur la sclérose systémiqueEU:BIOSBiosenic
20/03/202403:00GlobeNewswire Inc.BioSenic presents successful preclinical data on its ATO medication for controlling key symptoms at the 2024 Systemic Sclerosis World CongressEU:BIOSBiosenic
12/03/202403:00GlobeNewswire Inc.BioSenic publie les détails de la stratégie d'administration optimisée pour OATO dans le traitement de la maladie chronique du greffon contre l'hôte en amont du prochain essai de phase 3EU:BIOSBiosenic
12/03/202403:00GlobeNewswire Inc.BioSenic releases details of optimized administration approach ahead of planned Phase 3 trial of OATO for chronic graft-versus-host diseaseEU:BIOSBiosenic
29/02/202403:00GlobeNewswire Inc.BioSenic S.A. : Information relative au nombre total de droits de vote et d’actionsEU:BIOSBiosenic
02/02/202413:30GlobeNewswire Inc.BioSenic lève 500 000 euros dans le cadre d'un placement privé d'actions nouvelles auprès de nouveaux investisseurs établisEU:BIOSBiosenic
02/02/202413:30GlobeNewswire Inc.BioSenic raises €500,000 in private placement of new shares with established new investorsEU:BIOSBiosenic
31/01/202406:30GlobeNewswire Inc.BioSenic soutient la prochaine conférence européenne sur la maladie du greffon contre l'hôteEU:BIOSBiosenic
31/01/202406:30GlobeNewswire Inc.BioSenic provides support to forthcoming European conference on graft-versus-host disease  EU:BIOSBiosenic
30/01/202403:00GlobeNewswire Inc.Le brevet de BioSenic est accordé au Canada pour une protection plus large de sa plate-forme thérapeutique ATOEU:BIOSBiosenic
30/01/202403:00GlobeNewswire Inc.BioSenic patent granted in Canada for broader protection of ATO therapeutic platformEU:BIOSBiosenic
25/01/202403:00GlobeNewswire Inc.BioSenic presents new Phase 3 data on JTA-004 to treat severe osteoarthritis pain at the 2024 OARSI World CongressEU:BIOSBiosenic
 Apresentando as notícias mais relevantes sobre:EU:BIOS

Seu Histórico Recente

LSE
17NY
Morgan St. 29
EU
HODLX
21Shares
BIT
I10064
IT0005590663 20241202 17
COIN
GRIMACEUSD
GrimaceCoin
EU
ORACB
Orange 2.955% 24jul2028
COIN
SCOOBYGBP
NYSE
KF.W
Korea Fund
LSE
RRS
Randgold Resources
TSXV
ABL
BIT
UC6MQP
Unicredit Bank
BIT
P1O9O7
BNP Paribas Issuance
USOTC
RDSMF
Red Star Macalline (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados